Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss
In the register
The register attaches this trial to DA-001 / DA-002 / DA-005 (Applied Biology), currently at “Phase 1/2” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- Phase 3
- Sponsor
- Applied Biology, Inc.
- Participants (registry)
- 516
- Start
- January 2025 (planned)
- Primary completion
- October 2025
- Study completion
- December 2025
- Last registry update
- December 2024
- Countries
- —
Conditions studied: Androgenetic Alopecia, Female Pattern Baldness, Male Pattern Baldness
Interventions: DA-005, Daniel Alain Botanical Supplement Treatment for Hair Loss, Topical minoxidil 5%, DA-002, Placebo Oral Tablet, Placebo Topical Solution
Other trials of DA-001 / DA-002 / DA-005
Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia
Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth
Pharmacokinetic Study of DA-020
Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia
Pharmacokinetic Study of Topical Phenylephrine
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.